Affiliation:
1. Universidade de São Paulo, Instituto de Ciências Biomédicas, Departamento de Imunologia, Cidade Universitária, São Paulo-SP 05508-900, Brazil
Abstract
ABSTRACT
Due to the increasing numbers of reported clinical cases of complement deficiency in medical centers, clinicians are now more aware of the role of the complement system in the protection against infections caused by microorganisms. Therefore, clinical laboratories are now prepared to perform a number of diagnostic tests of the complement system other than the standard 50% hemolytic component assay. Deficiencies of alternative complement pathway proteins are related to severe and recurrent infections; and the application of easy, reliable, and low-cost methods for their detection and distinction are always welcome, notably in developing countries. When activation of the alternative complement pathway is evaluated in hemolytic agarose plates, some but not all human sera cross-react to form a late linear lysis. Since the formation of this linear lysis is dependent on C3 and factor B, it is possible to use late linear lysis to routinely screen for the presence of deficiencies of alternative human complement pathway proteins such as factor B. Furthermore, since linear lysis is observed between normal human serum and primary C3-deficient serum but not between normal human serum and secondary C3-deficient serum caused by the lack of factor H or factor I, this assay may also be used to discriminate between primary and secondary C3 deficiencies.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference19 articles.
1. Abramson, N., C. C. Alper, P. J. Lachmann, F. S. Rosen, and J. H. Jand. 1971. Deficiency of C3 inactivator in man. J. Immunol.107:19-27.
2. Amadei, N., G. V. Baracho, V. Nudelman, W. Bastos, M. P. C. Florido, and L. Isaac. 2001. Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H. Scand. J. Immunol.53:615-621.
3. Ferreira de Paula, P., P. R. Júnior, V. P. L. Ferriani, V. Nudelman, and L. Isaac. 2001. Concentrations of regulatory complement proteins in Brazilian healthy children and adults. Mol. Immunol.38:88.
4. Ferriani, V. P. L., J. E. Barbosa, and I. F. Carvalho. 1999. Complement haemolytic activity (classical and alternative pathways), C3, C4, and factor B titers in healthy children. Acta Paediatr.88:1-4.
5. Lachmann P. J. and M. J. Hobart. 1978. Complement technology p. 5A.12-5A.13. In D. M. Weir (ed.) Handbook of experimental immunology vol. 1 3rd ed. Blackwell Scientific Publications Ltd. Oxford United Kingdom.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献